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Abstract
Gestational choriocarcinoma is a highly malignant tumor of trophoblastic cells with a propensity to
metastasize to various sites including lungs, vagina, brain, liver, kidney, and gastrointestinal tract, in
descending order of frequency. A 29-year-old Caucasian woman presented to the hospital as an
emergency with abdominal pain, hypotension, nausea and vomiting at about 6th month of a twin
delivery after in vitro fertilization. Our case probably represents the first case of metastatic
choriocarcinoma developed after in vitro fertilization, whether associted with or not, which was
cured successfully after chemotherapy.
Introduction
Gestational choriocarcinoma is a highly malignant tumor
of trophoblastic cells with a propensity to metastasize to
various sites including lungs, vagina, brain, liver, kidney,
and gastrointestinal tract, in descending order of fre-
quency. The ultimate cause of gestational trophoblastic
disease is claimed to be genetic in origin. No environ-
mental etiological factor has been implicated up to now
apart from deficient vitamin A precursor carotene in diet
[1]. The first case of choriocarcinoma after in vitro
fertilization (IVF) was reported by Flam F et al. [2] and
the second by Scott P et al [3].
We hereby report the third case diagnosed with sponta-
neous splenic rupture, a peculiar mode of presentation.
Being metastatic at presentation, it is also the first case ever
reported in the English literature. We also discuss possible
etiopathogenic role of IVF with gestational trophoblastic
disease.
Case presentation
A 29-year-old Caucasian woman presented to the hospital
as an emergency with abdominal pain, hypotension,
nausea and vomiting at about 6th month of a twin
delivery.
Sixteen months previously she had been operated on due
to vaginal bleeding. Pathologic examination at that time
revealed necrotic chorion villi and chronic endometritis.
Thirty-nine months previously she had been started on an
in vito fertilization protocol due to the diagnosis of
infertility. The regimen consisted of recombinat FSH
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dotropin (Humagon, Organon, Turkey), human chorionic
gonadotropin (Pregnyl, Organon, Turkey), leuprolide
acetate (Lucrin, Abbott Laboratories, Turkey) and LHRH
analog (Suprecur, Aventis, Turkey). She was continued on
this treatment for two months and stopped when doctors
told her husband had azospermia. One month later
another 2 months hormonotherapy failed to generate
oocytes. Seven months later she was again started on
gestoden and ethynyestradiol (Ginera, Schering, Turkey)
together with leuprolide acetate and recombinant
FSH. After successful collection of oocytes in vitro
fertilization was achieved and she became pregnant with
twins. Pregnancy was supported with progestogen tablets
up until 10th week of gestation. She had nausea and
vomiting starting from the 4th week till 24th week of
gestation. She delivered two healthy babies at term.
Postpartum bleeding continued for two months and
dilatation & curettage were performed due to placental
retention and no abnormal pathology was noted at that
time. Irregular menses occured thereafter. No abnormality
was detected apart from a left sided ovarian cyst. Three
months before presentation symptoms of left sided
abdominal pain, nausea and vomiting started. Physical
examination and laboratory tests were reported to be
within normal limits. Proton pump inhibitors and
antacids gave no relief.
When she presented to the emergency room of the local
hospital, rigidity and rebound tenderness were detected on
abdominal examination. Abdominal ultrasonography
revealed intraabdominal fluid and solid mass in the
spleen. Splenectomy was performed with the diagnosis of
spontaneous splenic rupture and she recovered unevent-
fully. The diagnosis of a local pathologist was diffuse large
cell non-Hodgkin lymphoma (NHL). She was referred to
the oncology clinic of our University Hospital.
Paraffin blocks were obtained and transferred to our
hematopathology department. Microscopic features were
inconsistent with NHL. However, there was a necrotic and
hemorrhagic tumor composed of pleomorphic cytokeratin
positive epithelial cells with round nuclei and large
cytoplasm. These cells were surrounded with cytokeratin
(-) and b-HCG(+) sincyciotrophoblastic cells. The defini-
tive pathologic diagnosis was metastatic choriocarcinoma.
Computerized tomography (CT) scan of the abdomen and
pelvisshowedbilateralovariancysts,a2cmleftsidedrenal
lesion, and bilateral inguinal lymph nodes. CT scan of the
chest revealed aortopulmonary lymph nodes less than
1 cm in diameter and minor parancymal nodules less than
5 mm in diameter. Cranial magnetic resonance imaging
was normal. Plasma beta-human chorionic gonadotropin
(b-HCG) level was found be 7991 mIU/mL (normal value:
0-3 in males and nonpregnant females). She was treated
with 4 cycles of BEP regimen (cisplatin, bleomycin and
etoposide) starting from 8 months after antecedent
pregnancy. Her b-HCG level dropped to 18,3 mIU/mL
after the first cycle and <1 mIU/mL after the second
cycle and remained low thereafter. She has no sign of
recurrence for the last 25 months of follow-up.
Discussion
Gestational choriocarcinoma is the most malignant form
of a group of tumors including complete and partial molar
pregnancy, invasive mole, placental site trophoblastic
tumor, and choriocarcinoma. They are collectively
known as gestational trophoblastic disease. Although
choriocarcinoma has a very high propensity to metastasize
to various sites including brain it has also a very high cure
rate. Nongestational choriocarcinoma also occurs and is
usually resistant to therapy [4]. The precise molecular
pathogenesis of gestational trophoblastic disease is yet to
be elucidated. Genetics has a well established role. Kajii
reported that all chromosomes in true moles (complete
moles) are of paternal origin (androgenetic) [5]. Cytoge-
netic analysis revealed that in 90% of the time tropho-
blasts have 46XX diploid pattern all derived from the
sperm. In complete moles no maternal DNA is present in
the ovum. Sometimes two sperms can fertilize one empty
ovum. In both cases embryonic development does not
occur. Choriocarcinomas arise much more frequently
from complete moles (2%).
Ethnic origin, age, diet and oral contraceptives have been
implicated as a risk factor for gestational trophoblastic
disease (GTD). On the other hand, there are several case
reports showing development of GTD after IVF. An
attempt to explain the relationship between infertility, its
treatment and GTD by Bates et al. did not find a potential
association [6].
Franceschi et al. reported that women who used fertility
drugs were not at increased risk of developing ovarian
cancers compared with women who did not [7]. One year
later Rossing found that only clomiphene citrate may be
associated with ovarian cancer but only after using it more
than 12 months [8]. A study based on a large cohort of IVF
patients reported incresed incidence of uterine sarcoma
but not choriocarcinoma [9].
In conclusion, our case probably represents the first case of
metastatic choriocarcinoma developed after in vitro
fertilization, whether associted with or not, which was
cured successfully after chemotherapy.
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